search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ANTI-AGEING 21 T=28 D Placebo cream 0 -1.2% -5 -10 -15 -20 -25 *** p<0.001 Figure 8: Skin firmness and elasticity.


(average of 15% with a maximum of 57%), greatly increasing the skin elasticity.


Skin thickness: (Aloka alpha6 pro-sound ultrasound machine, Hitachi) The skin thickness was measured by ultrasound, observing that there is an increase of it, up to 26% at 56 days, with a stratum corneum visibly strengthened and a re-densified skin.


Clinical evaluation of wrinkles (crow’s feet):


Depth and volume, and skin roughness, (Ra parameter)


l Depth: The active significantly reduced wrinkle depth at 28 days (an average of 19% with a maximum reduction of 37%) and at 56 days (21% on average, with a maximum reduction of 41%)


l Volume: The active significantly reduced the wrinkle volume at 28 days (average of 8% with a maximum reduction of 33%) and at 56 days (13% average, and maximum


reduction of 38%)


l Skin Roughness: The active significantly reduced the skin roughness at 28 days (average of 3%, up to 10% reduction), and at 56 days (with an average of 6% and up to 18% reduction)


l Skin profilometry (PRIMOS 3D, GFMesstechnik GmbH) and digital images: The images show an improvement of skin complexion, a more even texture and a clear reduction of wrinkles.


-17% ***


-4.6%


Cream with 1% Olea VitaePLF


T=56 D Placebo cream


Cream with 1% Olea VitaePLF


20 15 10 5 0


-5 -10


-20% ***


-7%


*** p<0.001 **p<0.01


T=28 D *** +16% T=56 D


+15% **


Placebo cream -0.5%


Placebo cream


Cream with 1% Olea VitaePLF


Cream with 1% Olea VitaePLF


Do your sun care products meet the


UV-blocking demands 


Asian-Pacific consumers seek skincare products with


long-lasting UV protection while promoting high degrees of skin protection. To meet this growing demand,


formulators must innovate their products to include UV-blocking ingredients that also guard skin from air


pollution and tropical humidity. Our new hybrid technology, EPITEX™ 99 Polymer, has the solution. Building on the best features of both acrylic and silicone acrylate chemistries, EPITEX™ 99 Polymer delivers the high SPF and long-lasting wear that consumers desire for perfect skin protection.


dow.com November 2019 ® and ™ are Trademarks of The Dow Chemical Company © 2019


PERSONAL CARE ASIA PACIFIC


Decrease in Uf (vs initial time)


Increase in Ur/Ue (vs initial time)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120